Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 37 checked references that resolve
resolves10.1164/rccm.2009-040GLAn Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
resolves10.1164/rccm.201105-0840OCForced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference
resolves10.1056/NEJMp1500526Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
resolves10.1164/rccm.201508-1546OCPredictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis
resolves10.1126/scitranslmed.3005964Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
resolves10.1016/S2213-2600(17)30349-1Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
resolves10.1371/journal.pone.0037708The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis
resolves10.1155/2016/4759040Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
resolves10.1016/S2213-2600(18)30185-1Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials
resolves10.1152/ajplung.00139.2012Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis
resolves10.1164/ajrccm.165.2.ats01American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
resolves10.18637/jss.v039.i05Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
resolves10.18637/jss.v061.i08<b>OptimalCutpoints</b>: An<i>R</i>Package for Selecting Optimal Cutpoints in Diagnostic Tests
resolves10.1056/NEJMoa1113354Prednisone, Azathioprine, and
<i>N</i>
-Acetylcysteine for Pulmonary Fibrosis
resolves10.1056/NEJMoa1402582A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
resolves10.1164/rccm.201804-0761OCPrognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation
resolves10.1016/S2213-2600(17)30430-7An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
resolves10.1172/JCI16861Regulation of pulmonary fibrosis by chemokine receptor CXCR3
resolves10.1016/j.cyto.2013.12.003Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients
resolves10.1007/s00439-009-0666-1MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility
checked 2026-07-25 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.